Nisshin OilliO Group, Ltd.2602
▲ PositiveCapitalrelevance
Recurring profit up 66.6% and margin improved, beating expectations.
Impact on stocks 1
Synthetic Biology (non-pharma)
Nisshin OilliO Group, Ltd.Nisshin Oillio Group reported consolidated recurring profit of 5.17 billion yen for the first quarter of the fiscal year ending March 2027, up 66.6% from the same period a year earlier. This represents a progress rate of 28.8% against the full-year forecast of 18 billion yen, roughly in line with the five-year average of 28.5%. The operating profit margin for the April–June quarter improved to 4.2% from 2.8% a year ago.
Nisshin OilliO Group, Ltd.Recurring profit up 66.6% and margin improved, beating expectations.